Your browser doesn't support javascript.
loading
Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-γ and cyclo-oxygenase-2.
Ishola, Ismail O; Tijani, Habeeb K; Dosumu, Olufunke O; Anunobi, Charles C; Oshodi, Tolulope O.
Afiliação
  • Ishola IO; Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, 234, Lagos, Nigeria.
  • Tijani HK; Department of Surgery, Urology Unit, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Dosumu OO; Department of Anatomy, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Anunobi CC; Department of Anatomic and Molecular Pathology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Oshodi TO; Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, 234, Lagos, Nigeria.
Fundam Clin Pharmacol ; 31(6): 652-662, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28636803

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Inibidores de Hidroximetilglutaril-CoA Redutases / PPAR gama / Ciclo-Oxigenase 2 / Atorvastatina Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Inibidores de Hidroximetilglutaril-CoA Redutases / PPAR gama / Ciclo-Oxigenase 2 / Atorvastatina Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article